The eradication rates of the Bismuth-containing quadruple regimen overall, fornaïve, previously failed to respond to Helicobacter pylori eradication therapy on intention to treat (ITT) and per-protocol (PP) analysis were 97.4 - 97.3%; 98.3 - 98.1% and 96.3 - 96.2%.